121 related articles for article (PubMed ID: 34265522)
21. Novel variants in outer protein surface of flavin-containing monooxygenase 3 found in an Argentinian case with impaired capacity for trimethylamine N-oxygenation.
Dionisio L; Shimizu M; Stupniki S; Oyama S; Aztiria E; Alda M; Yamazaki H; Spitzmaul G
Drug Metab Pharmacokinet; 2020 Aug; 35(4):383-388. PubMed ID: 32653296
[TBL] [Abstract][Full Text] [Related]
22. Genetic variants of flavin-containing monooxygenase 3 (FMO3) derived from Japanese subjects with the trimethylaminuria phenotype and whole-genome sequence data from a large Japanese database.
Shimizu M; Yoda H; Nakakuki K; Saso A; Saito I; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
Drug Metab Pharmacokinet; 2019 Oct; 34(5):334-339. PubMed ID: 31401033
[TBL] [Abstract][Full Text] [Related]
23. The metabolic fate of isotopically labeled trimethylamine-N-oxide (TMAO) in humans.
Taesuwan S; Cho CE; Malysheva OV; Bender E; King JH; Yan J; Thalacker-Mercer AE; Caudill MA
J Nutr Biochem; 2017 Jul; 45():77-82. PubMed ID: 28433924
[TBL] [Abstract][Full Text] [Related]
24. Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients.
Robinson-Cohen C; Newitt R; Shen DD; Rettie AE; Kestenbaum BR; Himmelfarb J; Yeung CK
PLoS One; 2016; 11(8):e0161074. PubMed ID: 27513517
[TBL] [Abstract][Full Text] [Related]
25. Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria.
Zhang J; Tran Q; Lattard V; Cashman JR
Pharmacogenetics; 2003 Aug; 13(8):495-500. PubMed ID: 12893987
[TBL] [Abstract][Full Text] [Related]
26. Transient trimethylaminuria related to menstruation.
Shimizu M; Cashman JR; Yamazaki H
BMC Med Genet; 2007 Jan; 8():2. PubMed ID: 17257434
[TBL] [Abstract][Full Text] [Related]
27. Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.
Shimizu M; Yano H; Nagashima S; Murayama N; Zhang J; Cashman JR; Yamazaki H
Drug Metab Dispos; 2007 Mar; 35(3):328-30. PubMed ID: 17142560
[TBL] [Abstract][Full Text] [Related]
28. Effect of dietary choline supplementation under different flavin-containing monooxygenase 3 genotypes on trimethylamine metabolism in laying hens.
Wang J; Yue HY; Xia ZQ; Wu SG; Zhang HJ; Ji F; Xu L; Qi GH
Poult Sci; 2012 Sep; 91(9):2221-8. PubMed ID: 22912456
[TBL] [Abstract][Full Text] [Related]
29. Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis.
Liang X; Zhang Z; Lv Y; Tong L; Liu T; Yi H; Zhou X; Yu Z; Tian X; Cui Q; Yang J; Gong P; Zhang L
Nutrition; 2020; 79-80():110941. PubMed ID: 32858376
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the Anti-Tumour Effect of Xuefu Zhuyu Decoction Based on Network Pharmacology and Experimental Verification in
Wang S; Wu C; Li Y; Ye B; Wang S; Li G; Wu J; Liu S; Zhang M; Jia Y; Cao H; Jiang C; Wu F
Front Pharmacol; 2022; 13():922457. PubMed ID: 35903326
[No Abstract] [Full Text] [Related]
31. Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.
Zhou J; Shephard EA
Mutat Res; 2006 Jun; 612(3):165-171. PubMed ID: 16481213
[TBL] [Abstract][Full Text] [Related]
32. Trimethylaminuria and a human FMO3 mutation database.
Hernandez D; Addou S; Lee D; Orengo C; Shephard EA; Phillips IR
Hum Mutat; 2003 Sep; 22(3):209-13. PubMed ID: 12938085
[TBL] [Abstract][Full Text] [Related]
33. Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?
Coutinho-Wolino KS; de F Cardozo LFM; de Oliveira Leal V; Mafra D; Stockler-Pinto MB
Eur J Nutr; 2021 Oct; 60(7):3567-3584. PubMed ID: 33533968
[TBL] [Abstract][Full Text] [Related]
34. Potential synergism and inhibitors to multiple target enzymes of Xuefu Zhuyu Decoction in cardiac disease therapeutics: a computational approach.
Huang Q; Qiao X; Xu X
Bioorg Med Chem Lett; 2007 Mar; 17(6):1779-83. PubMed ID: 17236764
[TBL] [Abstract][Full Text] [Related]
35. [Mechanism of Xuefu Zhuyu Decoction in treatment of myocardial infarction based on network pharmacology and molecular docking].
Lin JG; Yao KW; Wang QQ; Hua X
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):885-893. PubMed ID: 33645093
[TBL] [Abstract][Full Text] [Related]
36. Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
Shimizu M; Kobayashi Y; Hayashi S; Aoki Y; Yamazaki H
Mol Genet Metab; 2012 Nov; 107(3):330-4. PubMed ID: 22819296
[TBL] [Abstract][Full Text] [Related]
37. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development.
Simó C; García-Cañas V
Food Funct; 2020 Aug; 11(8):6745-6776. PubMed ID: 32686802
[TBL] [Abstract][Full Text] [Related]
38. The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance.
Warrier M; Shih DM; Burrows AC; Ferguson D; Gromovsky AD; Brown AL; Marshall S; McDaniel A; Schugar RC; Wang Z; Sacks J; Rong X; Vallim TA; Chou J; Ivanova PT; Myers DS; Brown HA; Lee RG; Crooke RM; Graham MJ; Liu X; Parini P; Tontonoz P; Lusis AJ; Hazen SL; Temel RE; Brown JM
Cell Rep; 2015 Jan; 10(3):326-338. PubMed ID: 25600868
[TBL] [Abstract][Full Text] [Related]
39. Trimethylamine-N-Oxide: Friend, Foe, or Simply Caught in the Cross-Fire?
Cho CE; Caudill MA
Trends Endocrinol Metab; 2017 Feb; 28(2):121-130. PubMed ID: 27825547
[TBL] [Abstract][Full Text] [Related]
40. Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis.
Schugar RC; Brown JM
Curr Opin Lipidol; 2015 Oct; 26(5):426-31. PubMed ID: 26218418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
